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NeuroinflammationCerebral magnetic resonance elastography (MRE) measures the viscoelastic properties of brain tissues in vivo.
It was recently shown that brain viscoelasticity is reduced in patients with multiple sclerosis (MS), highlight-
ing the potential of cerebral MRE to detect tissue pathology during neuroinflammation. To further investigate
the relationship between inflammation and brain viscoelasticity, we applied MRE to a mouse model of MS,
experimental autoimmune encephalomyelitis (EAE). EAE was induced and monitored by MRE in a 7-tesla an-
imal MRI scanner over 4 weeks. At the peak of the disease (day 14 after immunization), we detected a signif-
icant decrease in both the storage modulus (G′) and the loss modulus (G″), indicating that both the elasticity
and the viscosity of the brain are reduced during acute inflammation. Interestingly, these parameters normal-
ized at a later time point (day 28) corresponding to the clinical recovery phase. Consistent with this, we
observed a clear correlation between viscoelastic tissue alteration and the magnitude of perivascular T cell in-
filtration at both day 14 and day 28. Hence, acute neuroinflammation is associated with reduced mechanical
cohesion of brain tissues. Moreover, the reduction of brain viscoelasticity appears to be a reversible process,
which is restored when inflammation resolves. For the first time, our study has demonstrated the applicability
of cerebral MRE in EAE, and showed that this novel imaging technology is highly sensitive to early tissue alter-
ations resulting from the inflammatory processes. Thus, MREmay serve tomonitor early stages of perivascular
immune infiltration during neuroinflammation.
© 2012 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
In multiple sclerosis (MS), diffuse brain parenchymal damage ap-
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Inc. Open access under CC BY-NC-ND lrepresent a major cause of clinical symptoms. Magnetic resonance im-
aging (MRI) is limited in identifying diffuse patterns of brain pathology
in MS (Miller et al., 2003), and conventional MRI relies on the quantifi-
cation and characterization of lesions, which are often poorly correlated
with clinical disease manifestations (Barkhof, 2002). Consequently,
there is a need to develop alternative MRI approaches, and to further
improve the diagnostic specificity and predictive value of MRI in MS.
Magnetic resonance elastography (MRE) represents one of the
emerging alternative approaches to MRI (Muthupillai et al., 1995).
MRE is capable of measuring the effective viscoelastic constants of
the living brain (Green et al., 2008; Klatt et al., 2007; Kruse et al.,
2008). This yields information on the physico-mechanical properties
of the tissue, i.e. its relative “softness” or “rigidness”. In the brain, the
viscoelastic constants are dictated by the mechanical properties and
interactions of neurons, glial cells (Lu et al., 2006) and the vascular
tree. Interstitial fluid pressure, as well as vascular- and CSF-pressures,
influences the mechanical properties of brain tissues (Tully and
Ventikos, 2011). Thus, the elastographic properties of brain tissues are
sensitive to disruptions of the complex interactions between brain con-
stituents that occur during neuropathophysiological processes.icense.
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the human brain is reduced in the course of physiological aging (Sack
et al., 2011), and as a consequence of diseases such as hydrocephalus
(Streitberger et al., 2011) and Alzheimer's disease (Murphy et al.,
2011). Importantly, we recently showed that this is also the case in
MS (Streitberger et al., 2012; Wuerfel et al., 2010). Nevertheless, the
histopathologic alterations that may account for this reported loss in
brain elasticity are still undefined. It may be that a common process of
mechanical degradation underlies several neurological disorders, or
that similar viscoelastic alterations in the brain are the result of distinct
disorder-specific pathophysiological mechanisms. To unravel this ques-
tion, it is necessary to extend MRE investigations to animal disease
models (Atay et al., 2008; Clayton et al., 2011; Pattison et al., 2010).
Mouse MRE is similar to MRE in humans, despite a smaller field of
view. Harmonic vibrations from an external source are applied to the an-
imal in the scanner, and shear waves are induced in the tissue. These
waves are detected by motion-sensitive MRI sequences, and the data
processed to yield the shear modulus, G* (Mariappan et al., 2010). The
shear modulus is a complex number: the real part, G′, is referred to as
the storage modulus, and the imaginary part, G″ is called the loss modu-
lus. The storagemodulusG′ reflects the elasticity of the tissue, and is relat-
ed to the inherent mechanical rigidity of the tissue matrix. The loss
modulus G″ reflects the viscosity of the tissue, related to both the me-
chanical rigidity and the tissue architecture. The ratio of G″/G′ reflects
the complexity of the tissue architecture — this can be understood as
the density and topological arrangement of structural interactions be-
tween cellular and non-cellular components of biological tissues, which
collectively gives rise to the mechanical properties of a given tissue.
Histopathophysiological processes disrupt these intricate struc-
tural interactions resulting in a transient (acute) or sustained (chronic)
alteration of the mechanical properties of tissues. These alterations can
be detected by changes in the elastographic parameters using MRE. A
reduction in the values of G′ and G″, while maintaining a constant
ratio of these parameters, is interpreted as a “weakening” or “softening”
of themechanical rigidity of tissue, depicted schematically in Fig. 1A. An
alteration of the ratio of G′ and G″ is interpreted as a change in the com-
plexity of the tissue architecture, which could be indicative of a more
severe degradation of the tissue structure (Fig. 1A). This interpretation
implies that G″/G′ is constant with excitation frequency — a condition
which is fulfilled if the tissue's viscoelastic response can be described
by a powerlaw |G*|~ωα with ω being the angular drive frequency
and α∼arctan(G″/G ′). Such a powerlaw model has been applied
in multiple studies of MRE of muscle (Klatt et al., 2010), liver (Asbach
et al., 2010) and brain (Sack et al., 2009) and has recently been analyzed
in terms of structural parameters such as network density and network
fractal dimensions (Guo et al., 2012; Posnansky et al., 2012).
Our recent findings (Streitberger et al., 2012; Wuerfel et al., 2010)
indicate that G′, G″ and the ratio G″/G″ can provide information about
histological alterations of the brain associated with MS. Based on this,
we hypothesize that alterations in these parameters may occur also in
the animal model when neuroinflammation is present.
Therefore, we applied MRE to study possible neuroinflammation-
associated alterations of mechanical properties of mouse brain tissue,
and to determine the viscoelastic changes over the course of experi-
mental autoimmune encephalomyelitis (EAE), the animal model
of MS. The flexibility of the animal model affords the possibility to
examine how histopathological features relate to MRE measure-
ments, and to expand the utility of MRE as a tool to monitor cellular
and molecular changes in the pathology of MS.
2. Material and methods
2.1. Animals
All procedures were performed in accordance with protocols
approved by the local animal welfare committee in accordance tonational and international guidelines to minimize discomfort to ani-
mals (86/609/EEC). SJL mice were purchased from Charles River
Laboratories, (Sulzfeld, Germany) and were housed under standard
conditions.
2.2. Experimental autoimmune encephalomyelitis
SJL mice were immunized subcutaneously with 250 mg of pro-
teolipid protein (PLP) peptide 139–151 (purity 95%; Pepceuticals,
Leicester, UK) emulsified in an equal volume of PBS and complete
Freund's adjuvant containing 6 mg/ml Mycobacterium tuberculosis
H37Ra (Difco, Franklin Lakes, NJ). Pertussis toxin (200 ng per mouse;
List) was injected intraperitoneally on the day of immunization (day
0) and again 2 days later. After immunization, mice were monitored
daily for clinical signs and scored as follows: 0, no disease; 1, tail paral-
ysis; 2, paraparesis; 3, paraplegia; 4, paraplegiawith forelimbweakness
or paralysis; and 5,moribund or dead animals. The experimental design
is illustrated in the Appendix (Fig. S1).
2.3. Magnetic resonance elastography: data acquisition and processing
2.3.1. Mechanical stimulation
A schematic of the experimental setup is shown in Fig. 1B. The
vibration source was an electromagnetic coil (A) attached to a carbon
fiber piston (B), the end of which was mounted to the respiratory
mask with bite-bar transducer (C). The transducer was gimballed
through a rubber bearing (D) and retaining bracket (E) at the tem-
pered mouse bed (F). The entire setup was held in the center of the
magnet bore (G) by a plastic disk (H). Vibrations were produced by
applying a sinusoidal current of 900 Hz frequency to an air-cooled
Lorentz coil (I) in the fringe field of the MRI scanner. Frequency,
amplitude, and number of the sinusoidal oscillation cycles were con-
trolled by an arbitrary function generator connected via an audio
amplifier to the driving coil. The main polarization of the vibration
was transverse to the principal axis of the magnet field, with ampli-
tudes on the order of tens of micrometers.
2.3.2. Data acquisition
All measurements were performed on a 7 T scanner (Bruker
PharmaScan 70/16, Ettlingen, Germany) running ParaVision 4.0 soft-
ware and using a 20 mm diameter mouse head coil. The vibration was
initiated by a trigger pulse from the control unit of the scanner, the
timing of which was defined by a customized FLASH sequence. The im-
aging sequencewasmodified forMRE by a sinusoidalmotion sensitizing
gradient (MSG) in the through-plane direction, as described elsewhere
(Riek et al., 2011). The MSG strength was 285 mT/m, with a frequency
of 900 Hz, and 9 periods. To compensate for static phase contributions,
phase difference images were calculated from two images differing in
the sign of theMSG. Further imaging parameters were: a 128×128ma-
trix, 25 mmFoV, 14.3 ms echo time (TE), 116.2 ms repetition time (TR),
eight dynamic scans over a vibration period, one transverse 2-mm slice,
and an acquisition time of 20 min.
2.3.3. Data analysis
Image preprocessing involved subtraction of complex wave im-
ages for eliminating static phase shifts, phase unwrapping, and con-
version of phases to deflections (in units of microns) by a coefficient
incorporating vibration frequency and MSG characteristics (Asbach
et al., 2008).
The resultingwave images u(x,y,t), with x and y as spatial coordinates
and t as time variable of the propagating shear waves, were temporally
Fourier-transformed. To remove noise and contributions of compression
waves, the resulting complex wave images U(x,y,ω) were filtered using
a Butterworth bandpass between the thresholds of 0.00135 m and
0.0124 mwavelengths. A 2D-Helmholtz inversion was applied to the fil-
tered data, yielding the complex shear modulus, G*(x,y)=−ρω2U(x,y)/
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Fig. 1. Hypothesis, experimental setup and baseline measurements for studying EAE with MRE in the mouse. A. Conceptual diagram illustrating the interpretation of the elastography
parameters. A reduction in the storage (G′), and loss (G″) moduli, while maintaining a constant ratio of these terms, is indicative of reduced mechanical rigidity of the tissue, which
can be associated with acute pathological processes leading to tissue alteration. A change in the ratio G″/G′ reflects alteration of the structural complexity of the tissue architecture,
which can be associated with severe tissue degradation in pathological states. B. A schematic of the mouse MRE apparatus: (A) driving coil; (B) carbon fiber piston; (C) respiratory
mask; (D) rubber bearing; (E) retaining bracket; (F) mouse bed; (G) magnet bore; (H) plastic disk; (I) Lorentz coil. C. Representative wave (deflection) images and complex modulus
maps, superimposed on T2-weighted anatomical scans of the mouse head. D. Plots of the storage and loss moduli of healthy mice show no significant changes over 28 days.
83K. Riek et al. / NeuroImage: Clinical 1 (2012) 81–90ΔU(x,y). Herein, Δ denotes the 2D-Laplace operator, while ρ is the mass
density which was set to 1000 kg/m3. G*(x,y,w) was spatially averaged
over the brain parenchymadisplayed in the image.We further analyzed
spatially averaged G*-values represented by the real part of G*,G ′=
Re(G*), known as storage modulus, the imaginary part G″=Im(G*),which is the loss modulus, the magnitude |G*|=abs(G*) and the loss
factor given by the ratio G″/G ′=Im(G*)/Re(G*). The storage, loss and
magnitude moduli are expressed in kilopascals (kPa). Fig. 1C shows
real and imaginary parts of complex wave images U(x,y) and complex
modulus images G*(x,y) in a representative mouse.
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Mice were transcardially perfused with zinc fixative (0.5% zinc
acetate, 0.5% zinc chloride, 0.05% calcium acetate). The brains were
removed and postfixed for 3 days at room temperature with zinc
fixative, cryoprotected by incubation overnight at 4 degrees in 30%
sucrose in PBS, then embedded in Tissue Tek O.C.T. (Optimal Cutting
Temperature) compound, and frozen in methylbutane with dry ice.
The frozen tissues were cut into 12 μm cryosections and stained
with hematoxylin and eosin (H&E) to assess inflammation and with
luxol fast blue to assess demyelination. For immunostaining, tissue sec-
tions were blocked with avidin, biotin, and normal goat serum, then
incubated overnight at 4 °C with rat anti-mouse CD3 antibody (BD
Pharmingen). The sections were then incubated with biotinylated
goat anti-rat IgG antibody (Vector Laboratories), then streptavidin-
conjugated peroxidase, and visualizedwith Vector NovaRED Peroxidase
substrate (Vector Laboratories) and counterstained with hematoxylin.
2.5. Quantitative RT PCR
After cryostat sections were prepared, the residual brain tissue
was reserved for RNA. Total RNA was extracted from the cerebellar
tissue by the guanidinium thiocyanate method, with the peqGOLD
TriFast reagent (Peqlab, Erlangen, Germany), according to the
manufacturer's instructions. The RNA was reverse transcribed, and
quantitative PCR (qPCR) carried out as described previously, using
an ABI Prism 7000 Sequence Detection System (Applied Biosystems)
(Millward et al., 2007). Primers and probes were from Eurofins
MWG Operon (Ebersberg, Germany), and the sequences used were
as follows: CD3epsilon: forward 5′-CCT CCT AGC TGT TGG CAC
TTG-3′, reverse 5′-CAC TGG TTC CTG AGA TGG AGA CT-3′, probe
5′FAM-CAG GAC GAT GCC GAG AAC ATT GAA TAC A-3′TAMRA. Cycle
threshold values were converted to arbitrary units using a standard
curve, and data are reported as the ratio of target gene expression
over 18s rRNA, which served as the endogenous reference.
2.6. Statistics
Elastography parameters were analyzed by paired t-test or 1-way
ANOVA with the Tukey's post hoc test, after verifying that the
data had a Gaussian distribution. Cumulative disease activity scores
(dimensionless) were derived from calculating the area under the
curve of the score-by-day plots for each individual mouse (Fleming
et al., 2005). Pearson correlations between the elastography parame-
ters and the PCR data were assessed. p-Valuesb0.05 were considered
significant. Calculations were done using GraphPad Prism v.4
(GraphPad software).
3. Results
3.1. Viscoelasticity of normal mouse brain
To generate baseline values of viscoelasticity measurements in
the healthy mouse brain, and to assess the accuracy and reproducibil-
ity of our MRE investigations, we monitored seven wildtype mice.
Representative color coded wave (deflection) images and complex
modulus maps are shown in Fig. 1C, superimposed on T2-weighted
anatomical images of the mouse head. Both the real and imaginary
parts of the complex wave and shear moduli are shown, after Fourier
transform (900 Hz component). The values for G′ andG″were obtained
from averaging over the color coded region. Themean storagemodulus
G′ was 6.098±0.167 kPa, and the mean loss modulus G″ was 1.987±
0.081 kPa (Fig. 1D). To evaluate the consistency of thesemeasurements,
the same seven unmanipulated wildtype mice were measured again
at two time points, 14 and 28 days after the initial measurements.
For both the storage and loss moduli, these later time points showedno significant difference from the baseline measurements (p=0.3804,
p=0.4686, respectively, ANOVA). Thus, in our hands, MRE measure-
ments in the mouse brain are reliable and reproducible both intra-
and inter-individually over this timescale.3.2. Brain viscoelasticity in mice is reduced during the acute phase of EAE
Next, we investigated how brain viscoelasticity is affected in mice
with EAE. MRE was performed at day 0, before immunization (to es-
tablish a baseline), and at day 14 post-immunization, when disease
was well established. Immunized mice started to develop EAE around
6–7 days after PLP-immunization (Fig. 2A). Four out of 14 immunized
mice showed no disease signs, as reflected by the cumulative disease
activity plot of each individual mouse (mean±sem 6.464±1.371,
Fig. 2B). We observed a significant reduction in G′ (5.988±0.1647
vs. 5.301±0.1620, mean kPa±sem), G″ (1.881±0.1121 vs. 1.617±
0.0909) and |G*| (6151±185.1 vs. 5500±179.1) in the EAE mice at
day 14 compared to day 0 (Figs. 2C–E). In contrast, we saw no change
in these parameters in 10 healthy non-immunized control mice mea-
sured at the same time points (mean kPa±sem d0 vs. d14, G′:
6.048±0.1202 vs. 6.034±0.1346; G″: 2.005±0.0710 vs. 1.885±
0.0995; |G*|: 6289±125.1 vs. 6264±160.2). As well, there were no
significant differences between the EAE and control mice in the base-
line measurements (prior to immunization). In both EAE and con-
trol mice, there was no difference in the ratio G″/G′ (EAE: 0.2991±
0.01175 vs. 0.3025±0.01007; control: 0.3334±0.00834 vs. 0.3099±
0.00889, Fig. 2F). As mentioned above, changes in the ratio G″/G′ re-
flects alterations in the complexity of the structural interactions in the
tissue. Thus, during the early acute EAE phase, rigidity of the tissue is
reduced, without affecting the tissue architecture.
Interestingly, when analyzing only those mice which were immu-
nized but which failed to develop clinically detectable signs of EAE,
we still observed statistically significant reductions in the same
elastography parameters as when considering the entire group of
EAE mice. Furthermore, we did not observe any statistically signifi-
cant correlation between the storage or loss moduli and either the
cumulative disease activity (calculated as the area under the curve
of the clinical score plots for each individual EAE mouse), or the clin-
ical score at time of MRE measurements (Appendix Fig. S2).3.3. Normalization of brain viscoelastic properties during the recovery
phase of EAE
PLP-induced EAE in SJL mice is characterized by a relapsing–
remitting course. To investigate the stability of the observed elastographic
changes over time during different EAE phases, we performed additional
experimentswith sequential MREmeasurements at day 0 and 14, as well
as at 28 days post immunization — a time when the clinical severity of
EAE in SJLmice generally subsides from its peak intensity inmost animals
(Fig. 3A). These mice also showed a wide range of disease severity, indi-
cated in the cumulative disease activity plot (mean±sem=12.77±
3.21, Fig. 3B). Five of the immunized mice were removed from the data
set due to premature death fromEAE, orMREmeasurement error. As pre-
viously observed, therewas a statistically significant reduction in the stor-
age (mean kPa±sem 6.058±0.1137 vs. 5.237±0.1985), loss (2.033±
0.0845 vs. 1.542±0.0789) and magnitude (6274±185.7 vs. 5489±
0.00924) moduli at day 14. However, during the recovery phase of
the disease, these parameters increased (d28 G′: 5.526±0.1595; G″:
1.697±0.0969; |G*|: 5793±237.2, Figs. 3C–E). Despite variation in indi-
vidual mice, the mean values at d28 were not significantly different
from the baseline measurements, suggesting that the tissue alterations
reflected by changes in MRE parameters may indeed have a transitory
or partially reversible nature. We did not detect any change in the ratio
G″/G′ (Fig. 3F).
Fig. 2. Brain viscoelasticity is reduced during acute inflammation. The EAE clinical course and plot of cumulative disease activity are shown in A and B. Significant reductions in the
storage modulus (elasticity) C, loss modulus (viscosity) D, and the magnitude modulus E at day 14 are seen in EAE mice, but not in controls. No change is seen in the ratio of G″/G′,
F. n=10 and n=14 for controls and EAE group, respectively.
85K. Riek et al. / NeuroImage: Clinical 1 (2012) 81–903.4. Changes in brain viscoelasticity correlate with the magnitude of
inflammation
To determine the histological correlates of the observed reduc-
tion of the elastography parameters, we investigated the extent of
inflammation and demyelination in the mouse brains extracted im-
mediately after MRE investigations on day 14 (Fig. 4). Staining with
H&E revealed brain lesions affecting principally the cerebellum as
expected for this animal model. A representative image of lesions in
white matter tracts in the cerebellum is shown in Fig. 4, in compari-
son to a healthy non-immunized control. At this time point no demy-
elinating lesions were observed in the brains of the EAE mice by luxol
fast blue staining (Fig. 4, LFB), although demyelinating lesions were
clearly present in the spinal cords of these mice (data not shown).
At the day 28 time point, some animals showed a reduction in
clinical disease severity which was associated with relatively mildinflammatory pathology, compared to the peak of disease. A represen-
tative image is also shown in Fig. 4. Demyelinating lesions were not
observed in the brains of mice at day 28, although they were still
present in the spinal cords.
In this model, inflammation is primarily mediated by auto-reactive
T cells. Immunohistochemical staining of CD3+ T cells in inflamed
areas confirmed that the majority of the infiltrated cells are indeed T
lymphocytes (representative images of mild and severe lesions are
shown in Figs. 5A, B). CD3 is a marker for all T cells, and in the healthy
non-inflamed CNS, CD3 mRNA is below the limit of detection by quan-
titative real-time PCR. During EAE, T cells infiltrate the CNS in sufficient
numbers allowing CD3 mRNA to be detectable. Thus the magnitude
of CD3 expression can serve as anunbiased, quantitative surrogatemea-
sure of the severity of CNS inflammation (Appendix Fig. S3). Using this
parameter, we found a clear, significant correlation between the degree
of T cell-mediated inflammation and the changes in the elastography
Fig. 3. Brain viscoelasticity normalizes during the recovery phase of EAE. The EAE clinical course and plot of cumulative disease activity are shown in A and B. In EAE mice, the
significant reductions in the storage modulus (elasticity) C, loss modulus (viscosity) D, and the magnitude modulus E seen at day 14 are normalized at day 28, and no longer
significantly different from the baseline values. No change is seen in the ratio of G″/G′, F. n=10 and n=10 for controls and EAE group.
86 K. Riek et al. / NeuroImage: Clinical 1 (2012) 81–90measurements: higher levels of CD3 expression were reflected by
greater reductions in the storage (r=−0.6197; p=0.0181), loss
(r=−0.6199; p=0.0180) and magnitude moduli (r=−0.6215; p=
0.0177), as shown in Figs. 5C–E, which includes data from both the d14
and d28 time points. There was no significant correlation between CD3
expression and the G″/G′ ratio (r=−0.2555; p=0.3739) (Fig. 5F).
4. Discussion
Previous studies of MRE applied to MS patients showed a clear
reduction in the viscoelasticity of diseased brains, as compared to
healthy controls (Streitberger et al., 2012; Wuerfel et al., 2010). To
investigate the cellular and molecular mechanisms underlying this
phenomenon, it was necessary to extend these investigations into
the animal model of CNS inflammation. To date, only a few studies
applying MRE in the mouse brain have been published (Atay et al.,
2008; Clayton et al., 2011; Schregel et al., 2011) and the present
study is the first to utilize this method in the EAE model. Our results
showed a robust and reproducible reduction of brain elasticity andviscosity associated with the magnitude of focal inflammation
during EAE. Importantly, MRE changes appeared to partially normal-
ize during the recovery phase of the disease, when inflammation was
resolved.
The application of MRE in experimental mouse models is a field
which is still under development, and standard values for the
elastography parameters of the healthy non-inflamed mouse CNS
have yet to be established. Therefore, in our study, we first aimed to
define the normal values of viscoelastic measurements in the mouse
brain, using a 7-teslaMR device. Our results show good correspondence
with recent mouse MRE studies (Clayton et al., 2011; Schregel et al.,
2011). However, numerous studies show discrepant results (Atay
et al., 2008; Mace et al., 2011; Vappou et al., 2008), due in part to ana-
tomical and technical differences, thus underscoring the necessity for
the establishment of a “gold standard” for in vivo elastography in the
mouse. Nevertheless, our measurements in healthy control mice show
good consistency (Fig. 1D), reflecting sufficient shearwave penetration,
appropriate filtering, and spatial averaging as applied to our data
(Clayton et al., 2011).
Fig. 4. Histological features in EAE. Representative images of hematoxylin and eosin (H&E) staining show absence of pathology in healthy controls, in contrast to robust inflamma-
tory lesions (arrows) in the cerebellum white matter at the peak of the disease (d14), and relatively milder lesions from the recovery phase (day 28). Staining with luxol fast blue
(LFB) indicates that the cerebellar lesions (arrows) are not associated with demyelination.
87K. Riek et al. / NeuroImage: Clinical 1 (2012) 81–90Our results showed that at the peak of clinical severity, day 14
post-immunization, both the storage and loss moduli, as well as the
magnitude modulus, were significantly reduced in the EAE animals.
In contrast, the control animals showed no changes in these parameters.
Therewas no significant change in the ratio of G″/G′, (an indicator of the
complexity of cellular and non-cellular structural interactions in tissue)
at the peak of EAE, indicating that acute CNS inflammation affects the
viscoelastic properties independently of alterations in tissue architec-
ture. This finding is in agreement with the observations in human
MS patients that the integrity of neuronal tissue is degraded compared
to healthy controls, while the structural complexity is preserved
(Wuerfel et al., 2010).
Next, we aimed to determine the effects of neuroinflammatory
processes on MRE parameters during the course of the disease. By
day 28, the reductions in the storage, loss and magnitude moduli
seen at day 14 had normalized to the point where they were not sig-
nificantly different from the values at baseline. Again, no significant
alterations of the G″/G′ ratio were observed. This indicates that the
tissue alterations detected by MRE at peak disease are at least partial-
ly reversible.
Interestingly, we observed statistically significant alterations of
the viscoelastic parameters even in mice that were immunized but
that failed to develop clinically detectable signs of EAE. It is importantto bear in mind that in such asymptomatic immunized mice, the ab-
sence of clinical signs does not exclude the possibility of pathological
tissue alterations, comparable with the well established phenomenon
in MS — the so-called “clinical–radiological paradox”, in which MRI-
detectable lesions can be found in patients also in the absence of
apparent clinical manifestation (Barkhof, 2002; Okuda et al., 2009).
In our study, we could not detect a statistically significant correla-
tion between any elastography parameter and either the cumulative
disease severity, or the clinical score on the day of MRE, even if the
asymptomatic mice were excluded from the analysis. However, this
finding is not entirely unexpected, given that the clinical scoring sys-
tem for EAE reflects damage affecting the spinal cord rather than the
brain (i.e. initial paresis and paralysis of the tail, followed by ascend-
ing paralysis of the hind and forelimbs). Thus, while pathology also
clearly occurs in the brain in EAE, there is no standardized scoring
system available to quantify brain involvement in this model. The
present study is consistent with our previous study of MRE in MS pa-
tients, in which the elastographic changes did not correlate with dis-
ease severity as measured by the Expanded Disability Status Scale
(EDSS) (Streitberger et al., 2012; Wuerfel et al., 2010).
While there was substantial heterogeneity in the magnitude of the
pathology at both day 14 and day 28 time points, the great majority of
inflammatory lesions in the brain and cerebellum had a perivascular
Fig. 5. Elastographic alterations correlate with CD3 epsilon expression. Immunohistochemical staining for CD3 reveals the presence of T lymphocytes in mild, A, and severe, B cer-
ebellar white matter lesions (arrows). The level of CD3 epsilon mRNA in the cerebellum (from both the d14 and d28 time points) detected by quantitative real-time PCR is signif-
icantly correlated with the magnitude of the storage modulus (elasticity) C, loss modulus (viscosity) D, and the magnitude modulus E values, but not with the ratio of G″/G′, F.
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Furthermore, luxol fast blue staining showed that these lesions
were not associated with demyelination. This was in contrast to the
spinal cord, which showed disseminated lesions with extensive pa-
renchymal infiltration and clear evidence of demyelination. Given
that the MRE measurements focused on the brain and cerebellum
exclusively, it seems likely that demyelination per se is not sufficient
to explain the changes in the elastography parameters, observed
at these acute time points. Furthermore, these results indicate that
MRE is highly sensitive to pathological changes, in that alterations
in the elastography parameters could be detected even in the absence
of severe tissue damage. Thus, inflammation, rather than macroscopic
tissue disruption, appears to affect MRE measurements in this animal
model, at these time points.
This interpretation is supported by the clear correlation between the
levels of CD3 epsilon expression and the storage, loss and magnitude
moduli— higher CD3 epsilon levels were associated with greater reduc-
tions in tissue integrity. This suggests that the CNS tissue alterations
revealed by MRE are indeed related to the severity of inflammation,and that MRE is sufficiently sensitive to detect such alterations even in
the absence of disseminated parenchymal inflammation. Although the
precise mechanisms underlying this relationship remain to be deter-
mined, one could speculate that the accumulation of immune cells in
the perivascular space may lead to a transient alteration of the CNS
parenchyma in the vicinity of the vessels or thatMRE is sensitive enough
to detect endothelial alterations in this early stage of inflammation.
The potential for MRE to reveal acute inflammatory changes in
CNS tissue represents an intriguing development. MRE has already
proven extremely useful for detecting tissue changes associated
with chronic degenerative processes, including aging (Sack et al.,
2011). Neurodegenerative processes are also implicated in EAE. Atro-
phy of the cerebellar cortex has been described in chronic stages of
EAE, 48–56 days post-immunization (MacKenzie-Graham et al.,
2006). While it is quite likely that atrophy in chronic EAE would
be associated with elastographic changes, in the present study the
MRE and histological assessment was completed by day 28 post-
immunization, well before the reported onset of atrophy. It therefore
seems unlikely that cerebellar atrophy per se can account for the MRE
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vations that these changes normalized with the resolution of inflam-
mation at day 28 suggest that reversible processes are responsible
for the viscoelastic alterations at day 14, rather than irreversible de-
generation and atrophy, at least at this acute time point.
In the present study, we focused the MRE investigations on the
brain, despite the fact, mentioned above, that the EAE model we
employed here generally shows greater, though not exclusive, patho-
logical involvement of the spinal cord. Thus it would be interesting to
extend the application of MRE to other disease models such as some
forms of “atypical” EAE models (Lees et al., 2008; Stromnes et al.,
2008), in which the disease manifests principally in the cerebellum
and brainstem, rather than the spinal cord.
With the current state of the art, MRE can provide consistent
quantitative values on a global scale, i.e. considering spatially aver-
aged constants. This permits the determination of elastographic
parameters in the entire tissue, and can address diffuse pathology.
The usefulness of this approach has already been demonstrated by
several studies in human liver (Asbach et al., 2008; Huwart et al.,
2007; Yin et al., 2007) and brain (Murphy et al., 2011; Streitberger
et al., 2011; Wuerfel et al., 2010). However, at present the technology
is limited in its capacity to address elastographic changes in discrete
regions of the brain. Specifically, confined boundary conditions
present in the murine brain may impose backscattering, which
could potentially cause standing waves and wave nodes. In those re-
gions, the wave analysis is biased and the resulting elastograms suffer
from severe inversion-related artifacts. Reconstruction methods are
being developed which address this issue by using advanced wave
models (Baghani et al., 2011; Okamoto et al., 2011; Van Houten
et al., 2011) or multifrequency inversion (Papazoglou et al., 2012).
In general, the technology of MRE continues to advance, and the
application of this method is expanding into new domains.
5. Conclusions
MRE holds great promise as a technique that can complement
conventional MRI approaches. The results of the present study dem-
onstrate that MRE can detect tissue alterations associated with
acute inflammation in the CNS. While the mechanisms underlying
these changes remain to be determined in future studies, the fact
that they were observed in the absence of demyelination, and were re-
versible, suggests that MRE has a high sensitivity to detect relatively
early and mild events in the pathological process such as perivascular
immune infiltrates. This speaks to the potential clinical utility of MRE
to reveal early events in CNS disease processes, and to monitor the
response to therapies applied in the earliest stages of the disease,
even before strong disruption of the blood brain barrier and marked
clinical disability are evident.
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